Roubaix Capital LLC Buys 31,599 Shares of Transcat, Inc. $TRNS

Roubaix Capital LLC purchased a new stake in Transcat, Inc. (NASDAQ:TRNS – Free Report) in the third quarter, Holdings Channel.com reports. The institutional investor purchased 31,599 shares of the scientific and technical instruments company’s stock, valued at approximately $2,794,000.

A number of other institutional investors have also recently bought and sold shares of the stock. White Pine Capital LLC acquired a new stake in Transcat during the 3rd quarter worth about $1,710,000. Russell Investments Group Ltd. lifted its position in shares of Transcat by 41.8% in the third quarter. Russell Investments Group Ltd. now owns 24,929 shares of the scientific and technical instruments company’s stock worth $2,204,000 after buying an additional 7,348 shares during the last quarter. R Squared Ltd acquired a new position in shares of Transcat during the 3rd quarter valued at about $274,000. Riverbridge Partners LLC increased its holdings in shares of Transcat by 8.4% during the 3rd quarter. Riverbridge Partners LLC now owns 219,452 shares of the scientific and technical instruments company’s stock valued at $19,404,000 after acquiring an additional 17,063 shares during the last quarter. Finally, Summit Creek Advisors LLC increased its holdings in shares of Transcat by 23.8% during the 3rd quarter. Summit Creek Advisors LLC now owns 58,135 shares of the scientific and technical instruments company’s stock valued at $5,140,000 after acquiring an additional 11,165 shares during the last quarter. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Insiders Place Their Bets

In other Transcat news, CEO Jaime A. Irick bought 2,275 shares of the firm’s stock in a transaction that occurred on Thursday, November 5th. The stock was purchased at an average price of $101.26 per share, for a total transaction of $230,366.50. Following the purchase, the chief executive officer directly owned 2,275 shares in the company, valued at $230,366.50. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.80% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

TRNS has been the topic of a number of recent analyst reports. Oppenheimer raised Transcat from a “market perform” rating to an “outperform” rating and set a $115.00 price objective on the stock in a research note on Wednesday, November 4th. Northland Securities raised Transcat from a “market perform” rating to an “outperform” rating and set a $95.00 target price for the company in a research report on Wednesday, October 21st. Zacks Research upgraded Transcat from a “hold” rating to a “strong-buy” rating in a report on Thursday, November 5th. Weiss Ratings reissued a “sell (d+)” rating on shares of Transcat in a research report on Tuesday, August 25th. Finally, CJS Securities started coverage on shares of Transcat in a research report on Tuesday, October 27th. They issued an “outperform” rating and a $115.00 price target on the stock. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $108.33.

Get Our Latest Report on Transcat

Transcat Stock Down 2.0%

Transcat stock opened at $99.65 on Wednesday. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.57 and a quick ratio of 2.19. Transcat, Inc. has a fifty-two week low of $50.23 and a fifty-two week high of $112.44. The firm has a fifty day moving average price of $89.65 and a two-hundred day moving average price of $83.95. The firm has a market cap of $936.71 million, a price-to-earnings ratio of 207.61 and a beta of 0.61.

Transcat (NASDAQ:TRNS – Get Free Report) last issued its quarterly earnings results on Tuesday, November 3rd. The scientific and technical instruments company reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.19. The company had revenue of $97.09 million for the quarter, compared to the consensus estimate of $92.46 million. Transcat had a return on equity of 6.14% and a net margin of 1.26%. As a group, analysts forecast that Transcat, Inc. will post 2.06 earnings per share for the current year.

Transcat Company Profile

(Free Report)

Transcat, Inc. provides calibration and related services, including instrument repair, inspection and compliance support. Its services help customers maintain the accuracy and reliability of equipment used in regulated and quality-sensitive operations. The company also distributes professional-grade test, measurement and control instruments from a range of manufacturers. Its offerings include equipment used to measure and monitor variables such as pressure, temperature, electrical signals and humidity.

See Also

Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS – Free Report).

Institutional Ownership by Quarter for Transcat (NASDAQ:TRNS)

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.